v3.26.1
Sale of Product Line - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 18 Months Ended
Mar. 31, 2024
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2026
Sale of Product Line          
Proceeds from the sale of product line   $ 309 $ 170    
Disposal Group, Disposed of by Sale, Not Discontinued Operations | MiMedx Group, Inc.          
Sale of Product Line          
Proceeds from the sale of product line $ 5,000        
Transaction | MiMedx Group, Inc.          
Sale of Product Line          
Amount minimum revenue share payments receivable 3,000     $ 3,000  
Amount minimum revenue share payments receivable current   1,300     $ 1,300
Variable Consideration   $ 0 $ 0    
Transaction | Minimum | MiMedx Group, Inc.          
Sale of Product Line          
Revenue sharing payments 3,000     3,000  
Variable consideration 3,000     3,000  
Transaction | Maximum | MiMedx Group, Inc.          
Sale of Product Line          
Revenue sharing payments 7,000     7,000  
Variable consideration 7,000     7,000  
Transaction | Disposal Group, Disposed of by Sale, Not Discontinued Operations | MiMedx Group, Inc.          
Sale of Product Line          
Net carrying value 800     800  
Carrying value 0     0  
Consideration received for inventory on-hand 400        
Consideration determined $ 8,400     8,400  
Gain on sale of product line       $ 7,600  
Revenue share payments collected         $ 1,700